Using ketoconazole shampoo daily can dry out hair, and most users recommend using it 1-2 times a week with conditioner. Some users combine it with minoxidil and finasteride for better hair growth results.
The user shared a 6-month progress update on hair loss treatment using Dutasteride (0.5mg), Minoxidil (5%), and Dermanator 2. They reported improved hair density and coverage, especially in the crown/mid-scalp, and are focusing on enhancing the hairline.
The user is seeking a gentle, fragrance-free daily shampoo for a sensitive scalp with mild psoriasis, considering options like Cleure, CeraVe, and Vanicream. They are also contemplating using Nizoral once a week despite concerns about its harshness.
The user successfully managed hair regrowth by using a combination of finasteride, dutasteride, minoxidil, and specific shampoos to treat seborrheic dermatitis. They emphasize the importance of maintaining a healthy scalp and are considering food intolerance tests to further address inflammation.
The user is considering stopping finasteride due to depression, anxiety, and difficulty building muscle, despite its effectiveness in stopping hair loss. Suggestions include reducing the dose, switching to topical solutions, or consulting a doctor for alternatives like dutasteride or RU58841.
16 citations
,
September 2018 in “Journal of Ethnopharmacology”
This review discusses the role of inheritance, androgens, and microinflammation in androgenetic alopecia and suggests some plant-based folk remedies may help address these factors but reports no new clinical results.
This study reports that specific hair care practices common among individuals with high-curl-pattern hair could exacerbate seborrheic dermatitis, presenting significant treatment challenges and psychological impacts, and emphasizes the need for further research to tailor culturally sensitive solutions.
In this commentary, the authors discuss emerging evidence primarily from pharmacovigilance data and retrospective studies indicating a potential association between GLP-1 receptor agonists, like semaglutide and tirzepatide, and hair loss, although causality remains unproven, prompting recommendations for patient monitoring and further research.
16 citations
,
February 2018 in “European Journal of Endocrinology”
This review discusses the challenges in measuring testosterone for assessing androgen excess in women and emphasizes the importance of quality control in laboratory methods, but it reports no new clinical results.
76 citations
,
January 2007 in “American Journal of Clinical Dermatology”
This review discusses the dermatologic features of PCOS as potential early indicators of the syndrome and notes that treatment of these conditions may enhance quality of life and psychological well-being, but it reports no new clinical results.